Compare Hims and Hers Health Inc (HIMS) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Logitech International SA — how do they compare? Hims and Hers Health Inc trades at $28.42 (market cap $6.89B), while Logitech International SA trades at $101.34 (market cap $14.63B). The key difference: Logitech International SA is far larger — about 2.1× Hims and Hers Health Inc's market cap, and Logitech International SA pays a 1.62% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Logitech International SA for 92 Days on average.
| HIMS | LOGI | |
|---|---|---|
Market Cap | $6.89B | $14.63B |
Volume | 5,446,628 | 440,764 |
Sector | Health | Technology |
52-Week High | $62.76 | $126.69 |
52-Week Low | $14.52 | $85.84 |
Typical Hold Time | 21 Days | 92 Days |
Enterprise Value | $7.60B | $12.96B |
Dividend Yield | — | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.
The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.
Logitech (LOGI) trades at $101.50, down 0.89% today, with a bullish technical signal and strong fundamental performance. Recent earnings beats, including Q2 2026 EPS of $1.85 versus $1.26 expected, highlight operational strength. The company maintains robust profitability with a net margin of 16.28% and ROE of 35.29%, supported by new product launches like the Zone Vibe Pro headset and gaming partnerships.
Outlook remains positive with analyst consensus target of $107, offering ~5% upside, though risks include chip shortages and competitive pressures. Revenue growth is projected to reach $4.9B in 2026, but investor sentiment is mixed amid macroeconomic headwinds. The stock's valuation at P/E 18.75 appears reasonable given earnings trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
